These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 10498592)

  • 21. Relapse in the external auditory canal of acute promyelocytic leukemia after treatment with all-trans retinoic acid.
    Tobita T; Shinjyo K; Yanagi M; Takeshita A; Ohnishi K; Ohno R
    Intern Med; 1997 Jul; 36(7):484-6. PubMed ID: 9240497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of elderly patients (> or =60 years) with newly diagnosed acute promyelocytic leukemia. Results of the Italian multicenter group GIMEMA with ATRA and idarubicin (AIDA) protocols.
    Mandelli F; Latagliata R; Avvisati G; Fazi P; Rodeghiero F; Leoni F; Gobbi M; Nobile F; Gallo E; Fanin R; Amadori S; Vignetti M; Fioritoni G; Ferrara F; Peta A; Giustolisi R; Broccia G; Petti MC; Lo-Coco F;
    Leukemia; 2003 Jun; 17(6):1085-90. PubMed ID: 12764372
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relapse of acute promyelocytic leukemia with PML-RARalpha mutant subclones independent of proximate all-trans retinoic acid selection pressure.
    Gallagher RE; Schachter-Tokarz EL; Zhou DC; Ding W; Kim SH; Sankoorikal BJ; Bi W; Livak KJ; Slack JL; Willman CL
    Leukemia; 2006 Apr; 20(4):556-62. PubMed ID: 16437139
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.
    Jurcic JG; Caron PC; Miller WH; Yao TJ; Maslak P; Finn RD; Larson SM; Warrell RP; Scheinberg DA
    Leukemia; 1995 Feb; 9(2):244-8. PubMed ID: 7869759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GIMEMA-AIEOPAIDA protocol for the treatment of newly diagnosed acute promyelocytic leukemia (APL) in children.
    Testi AM; Biondi A; Lo Coco F; Moleti ML; Giona F; Vignetti M; Menna G; Locatelli F; Pession A; Barisone E; De Rossi G; Diverio D; Micalizzi C; Aricò M; Basso G; Foa R; Mandelli F
    Blood; 2005 Jul; 106(2):447-53. PubMed ID: 15677559
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute promyelocytic leukemia in patients aged >70 years: the cure beyond the age.
    Finsinger P; Breccia M; Minotti C; Carmosino I; Girmenia C; Chisini M; Volpicelli P; Vozella F; Romano A; Montagna C; Colafigli G; Cimino G; Avvisati G; Petti MC; Lo-Coco F; Foà R; Latagliata R
    Ann Hematol; 2015 Feb; 94(2):195-200. PubMed ID: 25186786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Internal tandem duplication of the FLT3 gene confers poor overall survival in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based chemotherapy: an International Consortium on Acute Promyelocytic Leukemia study.
    Lucena-Araujo AR; Kim HT; Jacomo RH; Melo RA; Bittencourt R; Pasquini R; Pagnano K; Fagundes EM; Chauffaille Mde L; Chiattone CS; Lima AS; Ruiz-Argüelles G; Undurraga MS; Martinez L; Kwaan HC; Gallagher R; Niemeyer CM; Schrier SL; Tallman MS; Grimwade D; Ganser A; Berliner N; Ribeiro RC; Lo-Coco F; Löwenberg B; Sanz MA; Rego EM
    Ann Hematol; 2014 Dec; 93(12):2001-10. PubMed ID: 24981688
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Detecting PML-RARalpha transcript in acute promyelocytic leukemia using real-time quantitative RT-PCR.
    Zhu HH; Liu YR; Qin YZ; Jiang B; Shan FX; Wu SL; Yang PD; Zhao J; Lu DP
    Chin Med J (Engl); 2007 Oct; 120(20):1803-8. PubMed ID: 18028775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group.
    Lo-Coco F; Avvisati G; Vignetti M; Breccia M; Gallo E; Rambaldi A; Paoloni F; Fioritoni G; Ferrara F; Specchia G; Cimino G; Diverio D; Borlenghi E; Martinelli G; Di Raimondo F; Di Bona E; Fazi P; Peta A; Bosi A; Carella AM; Fabbiano F; Pogliani EM; Petti MC; Amadori S; Mandelli F;
    Blood; 2010 Oct; 116(17):3171-9. PubMed ID: 20644121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The PML-RAR alpha transcript in long-term follow-up of acute promyelocytic leukemia patients.
    Gameiro P; Vieira S; Carrara P; Silva AL; Diamond J; Botelho de Sousa A; Mehta AB; Prentice HG; Guimarães JE; Hoffbrand AV; Foroni L; Parreira A
    Haematologica; 2001 Jun; 86(6):577-85. PubMed ID: 11418366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Disappearance of PML/RAR alpha acute promyelocytic leukemia-associated transcript during consolidation chemotherapy.
    Martinelli G; Ottaviani E; Testoni N; Visani G; Diverio D; D'Elia G; Mandelli F; Tura S
    Haematologica; 1998 Nov; 83(11):985-8. PubMed ID: 9864917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of newly diagnosed and relapsed acute promyelocytic leukemia with intravenous liposomal all-trans retinoic acid.
    Douer D; Estey E; Santillana S; Bennett JM; Lopez-Bernstein G; Boehm K; Williams T
    Blood; 2001 Jan; 97(1):73-80. PubMed ID: 11133744
    [TBL] [Abstract][Full Text] [Related]  

  • 33. AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenance.
    Avvisati G; Lo-Coco F; Paoloni FP; Petti MC; Diverio D; Vignetti M; Latagliata R; Specchia G; Baccarani M; Di Bona E; Fioritoni G; Marmont F; Rambaldi A; Di Raimondo F; Kropp MG; Pizzolo G; Pogliani EM; Rossi G; Cantore N; Nobile F; Gabbas A; Ferrara F; Fazi P; Amadori S; Mandelli F;
    Blood; 2011 May; 117(18):4716-25. PubMed ID: 21385856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term intensive consolidation therapy after all-trans retinoic acid in acute promyelocytic leukemia.
    Sousa AB; Fernandes JP; Ferreira G; Bernardo M; Conduto A; Costa I; Cruz E; Gonçalves AJ; Monteiro A; Nunes O; Ribeiro P; Rodrigues AS; Sousa M; Veiga J; Gouveia J
    Am J Clin Oncol; 1999 Jun; 22(3):294-7. PubMed ID: 10362340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution.
    Hu J; Shen ZX; Sun GL; Chen SJ; Wang ZY; Chen Z
    Int J Hematol; 1999 Dec; 70(4):248-60. PubMed ID: 10643151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen.
    Thirugnanam R; George B; Chendamarai E; Lakshmi KM; Balasubramanian P; Viswabandya A; Srivastava A; Chandy M; Mathews V
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1479-84. PubMed ID: 19822309
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frontline therapy of acute promyelocytic leukemia: Randomized comparison of ATRA and intensified chemotherapy versus ATRA and anthracyclines.
    Lengfelder E; Görlich D; Nowak D; Spiekermann K; Haferlach C; Krug U; Kreuzer KA; Braess J; Schliemann C; Lindemann HW; Horst HA; Schiel X; Flasshove M; Hecht A; Schnittger S; Schneider S; Wörmann B; Hofmann WK; Berdel WE; Bormann E; Sauerland C; Büchner T; Hiddemann W;
    Eur J Haematol; 2018 Feb; 100(2):154-162. PubMed ID: 29114972
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feasibility and clinical significance of real-time quantitative RT-PCR assay of PML-RARalpha fusion transcript in patients with acute promyelocytic leukemia.
    Gu BW; Hu J; Xu L; Yan H; Jin WR; Zhu YM; Zhao WL; Niu C; Cao Q; Su XY; Gu J; Ying HY; Chen Y; Xiong SM; Shen ZX; Chen Z; Chen SJ
    Hematol J; 2001; 2(5):330-40. PubMed ID: 11920269
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged treatment with arsenic trioxide (ATO) and all-trans-retinoic acid (ATRA) for relapsed acute promyelocytic leukemia previously treated with ATRA and chemotherapy.
    Cicconi L; Breccia M; Franceschini L; Latagliata R; Molica M; Divona M; Diverio D; Rizzo M; Ottone T; Iaccarino L; Alfonso V; Foa R; Voso MT; Lo-Coco F
    Ann Hematol; 2018 Oct; 97(10):1797-1802. PubMed ID: 29951912
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hematological and molecular remission with combination chemotherapy in a patient with PLZF-RARalpha acute promyelocytic leukemia (APML).
    George B; Poonkuzhali B; Srivastava VM; Chandy M; Srivastava A
    Ann Hematol; 2005 Jun; 84(6):406-8. PubMed ID: 15592671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.